The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
To elucidate the key molecules, functions, and pathways that bridge mild cognitive impairment (MCI) and Alzheimer's disease (AD), we investigated open gene expression data sets. Differential gene expression profiles were analyzed and combined with potential MCI- and AD-related gene expression p...
Main Authors: | Ye Tao, Yu Han, Lujiao Yu, Qi Wang, Sean X. Leng, Haiyan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2020.00233/full |
Similar Items
-
Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
by: Daniela Bertens, et al.
Published: (2019-08-01) -
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD)
by: Andrea Brugnolo, et al.
Published: (2021-01-01) -
Single nucleotide polymorphism mutation related genes in bladder cancer for the treatment of patients: a study based on the TCGA database
by: Tengyun Long, et al.
Published: (2021-01-01) -
AD-NET: Age-adjust neural network for improved MCI to AD conversion prediction
by: Fei Gao, et al.
Published: (2020-01-01) -
The Use of EEG and ERPs in the Study of Aging and Mild Cognitive Impairment (MCI)
by: Kamal, Farooq
Published: (2021)